Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Nessan_Bermingham
|
| gptkbp:developedBy |
therapies for Huntington's disease
therapies for myotonic dystrophy |
| gptkbp:focusesOn |
neurological diseases
genetic medicines repeat expansion disorders |
| gptkbp:foundedIn |
2018
|
| gptkbp:fundedBy |
gptkb:Invus
gptkb:Pfizer_Ventures gptkb:Morningside_Ventures gptkb:Partners_Innovation_Fund gptkb:Atlas_Venture |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Triplet Therapeutics
|
| gptkbp:website |
https://www.triplettherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Nessan_Bermingham
|
| gptkbp:bfsLayer |
7
|